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Abstract
Background: Escherichia coli is frequently the first-choice host organism in expression of heterologous
recombinant proteins in basic research as well as in production of commercial, therapeutic polypeptides. Especially
the secretion of proteins into the culture medium of E. coli is advantageous compared to intracellular production
due to the ease in recovery of the recombinant protein. Since E. coli naturally is a poor secretor of proteins, a few
strategies for optimization of extracellular secretion have been described. We have previously reported efficient
secretion of the diagnostically interesting model protein Peb1 of Campylobacter jejuni into the growth medium of
Escherichia coli strain MKS12 (ΔfliCfliD). To generate a more detailed understanding of the molecular mechanisms
behind this interesting heterologous secretion system with biotechnological implications, we here analyzed further
the transport of Peb1 in the E. coli host.
Results: When mature Peb1 was expressed without its SecA-YEG -dependent signal sequence and without the
putative signal peptidase II recognition sequence in E. coli MKS111ΔHBB lacking the flagellar secretion complex, the
protein was found in the periplasm and growth medium which indicated a flagellum-independent translocation.
We assessed the Peb1 secretion proficiency by an exhaustive search for transport-affecting regions using a
transposition-based scanning mutagenesis strategy. Strikingly, insertion mutagenesis of only two segments, called
TAR1 (residues 42 and 43) and TAR2 (residues 173 to 180), prevented Peb1 secretion individually. We confirmed
the importance of TAR regions by subsequent site-specific mutagenesis and verified that the secretion deficiency
of Peb1 mutants was not due to insolubility or aggregation of the proteins in the cytoplasm. We found by cell
fractionation that the mutant proteins were present in the periplasm as well as in the cytoplasm of MKS12. Hence,
mutagenesis of TAR regions did not affect export of Peb1 across the cytoplasmic membrane, whereas its export
over the outer membrane was markedly impaired.
Conclusions: We propose that the localization of the model protein Peb1 in the growth medium of E. coli is due
to active secretion by a still unknown pathway of E. coli. The secretion apparently is a two-step process involving a
periplasmic step and the TAR regions.
Background
Protein secretion is one of the main means by which
bacteria interact with their environment. The interaction
may take place in a variety of manners: bacteria secrete
enzymes, toxins and other virulence factors, excrete
metabolic waste products, and export binding proteins
into the periplasm for import of nutrients or export of
toxic compounds. Bacteria also use different secretion
systems to assemble on their surface organelles for
motility, adhesion and injection of effector molecules
into host cells [1,2]. Bacterial protein secretion systems
are of great importance from a virulence-associated
viewpoint as potential targets for novel antibacterial
drugs [3] but are significant also commercially and ther-
apeutically due to the use of bacteria as protein factories
for the delivery of polypeptides into bacterial growth
medium [4,5].
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any medium, provided the original work is properly cited.In bacteria, secretion is regarded as active transport of
proteins from the cytoplasm to the exterior of the cell
[6]. In Gram-negative bacteria, the proteins to be
exported have to first cross the cytoplasmic membrane
(CM), usually at the cost of ATP hydrolysis, and further
the outer membrane (OM). Six distinct protein secretion
pathways have currently been described in Gram-nega-
tive bacteria, some of these to atomic detail [7-9]. Some
of the secretion pathways, i. e. the type 2 and type 5
secretion systems consist of separate protein complexes
on the two membranes [10-12], whereas others, i. e. the
type 1, type 3, type 4 and type 6 pathways form continu-
ous pores or tunnels crossing all the way from the cyto-
plasm to the exterior [13,14]. In addition to the
complexes specifically devoted to protein secretion, bac-
teria possess so-called ATP-binding cassette (ABC)
secretion systems, which carry a wide variety of sub-
strates across the CM. Of these, the ABC importers cat-
alyze the uptake of nutrients that are delivered to them
by specific periplasmic substrate-binding proteins
(PBPs), whereas ABC exporters are involved in the
transport of e.g. drugs, lipopolysaccharides, toxins as
well as proteins from the cytoplasm [13,15].
The food-borne human gastrointestinal pathogen
Campylobacter jejuni expresses the protein Peb1 [16],
which acts in distinct roles in separate compartments of
the bacterial cell. First, Peb1 is present on the bacterial
surface of all C. jejuni isolates analyzed, which makes it
a putative target for diagnostics, and is regarded as a
significant colonization and virulence factor. Antibodies
against Peb1 are found in sera derived from the majority
of patients convalescent from C. jejuni infection [16].
The protein mediates C. jejuni adherence in vitro to
HeLa cells and is required for C. jejuni colonization of
mice intestine [17,18]. Second, the major fraction of
Peb1 is present in the periplasm of C. jejuni and acts as
an aspartate/glutamate -binding PBP essential for opti-
mal microaerobic growth of C. jejuni on these amino
acids [19,20]. Finally, Peb1 is also found in minor
amounts in the culture supernatant, but it is not present
in the CM and OM [19]. For fulfilling each of its roles,
Peb1 must be efficiently exported to the correct cell
compartment. In the cytoplasm of C. jejuni, Peb1 carries
an N-terminal signal sequence, typical of proteins
secreted by the SecA-YEG pathway, which directs its
export across the CM. A processing site typical for sig-
nal peptidase II has additionally been predicted in the
N-terminus of Peb1, but the biological relevance of this
processing site as well as the mechanism for the further
transport of Peb1 from the periplasm across the OM in
C. jejuni are still unknown [20].
We have previously shown that Peb1 expressed with-
out its native SecA-YEG -dependent N-terminal secre-
tion sequence and without the putative processing site
for signal peptidase II is exported very efficiently into
the growth medium at a high concentration and purity
in an Escherichia coli flagellar mutant [21]. The reader
is referred to Chevance and Hughes for a more detailed
account on flagellar regulation and assembly [22]. Here
we further analyze and document this phenomenon in
order to increase the knowledge on how a heterologous
model protein may be transported across the cell wall
into the growth medium of E. coli and to broaden the
understanding of factors that influence heterologous
protein secretion in E. coli.W er e p o r tt h a tP e b 1i s
actively secreted in a flagellar-independent manner by
an unknown two-step process and that the secretion
is affected by mutagenesis of two distinct transport-
affecting regions in Peb1.
Results
Peb1 is transported from E. coli MKS12 also
independently of the flagellar secretion system
In a previous report, we showed that the E. coli strain
MKS12 (ΔfliCΔfliD), lacking the flagellar filament, is
able to secrete recombinant flagellin (FliC), FliC frag-
ments, FliC fusion proteins as well as heterologous pro-
teins, like the model Peb1 protein, into the growth
medium [21]. We also demonstrated that the extracellu-
lar location of these recombinant polypeptides was not a
result of leakage from the periplasm or cytoplasm or
lysis of the cells by showing the lack of the periplasmic
maltose binding protein as well as the cytoplasmic pro-
teins chloramphenicol acetyl transferase and GroEL in
the growth medium.
To generate a more detailed picture of the Peb1 trans-
port event in E. coli,w eh e r ea s s e s s e dt h er o l eo ft h ef l a -
gellar export gate on Peb1 secretion. To construct a host
strain lacking the flagellar export gate, the following
modifications in strain MKS12 were made. We con-
structed the E. coli strains MKS111 and MKS111ΔHBB
(see Table 1 for strains used), which are isogenic with
strain MKS12; MKS111 carries additionally a deletion in
the chromosomal gene encoding the transcriptional regu-
lator FlgM. The flgM deletion releases the flagellar-
specific sigma factor FliA, which is required for transcrip-
tion from the PfliC promotor used in this study [23]. In
strain MKS111ΔHBB, genes encoding flagellar basal body
structures, i.e. the rings, the rod, the hook as well as com-
ponents of the secretion apparatus, have additionally
been deleted from the chromosome. Consequently, FliA-
mediated transcription can proceed but flagellar filament
components are not secreted from the cytoplasm across
the membranes in strain MKS111ΔHBB. The ΔfliC gene
of the strains MKS12, MKS111 and MKS111ΔHBB was
complemented in trans with plasmids pLA25 and pLA31
(see Table 1 for plasmids used), which encode Peb1 with-
out the sequences encoding its native N-terminal leader
Anton et al. Microbial Cell Factories 2010, 9:97
http://www.microbialcellfactories.com/content/9/1/97
Page 2 of 16peptide and putative processing site for signal peptidase
II, and the FliC1-183 peptide, respectively. Western blot
analyses with anti-Peb1 and anti-flagella antibodies
showed that Peb1 was present in cell-free culture super-
natant of all the strains tested, whereas the FliC1-183
peptide, expressed similarly and used as a flagellum-
secreted control [21], remained intracellular in
MKS111ΔHBB (Figure 1A). The results showed that
Peb1 is secreted to the extracellular milieu also in the
strain lacking the flagellar export gate, whereas the
C-terminally truncated flagellin and the full-length FliC
(not shown) remain intracellular in the same strain. This
finding indicated that the secretion of Peb1 in E. coli also
can proceed independently of the flagellum.
Peb1 is present in the periplasmic space of E. coli
The finding that Peb1 is present in the growth medium
also in a mutant lacking the flagellar transport complex
prompted us to further analyze the phenomenon. To
compare the localization of Peb1 expressed from a mul-
ticopy plasmid and from a single-copy gene from the
chromosome, we first constructed the strain MKS12Plac-
peb1, which carries peb1 without signal sequences under
a constitutive lac promoter (Plac)t h a tl a c k st h elac
operator region of Plac in the fliC deletion site on the
chromosome of MKS12. We then prepared periplasmic
fractions and cell samples of the E. coli strains MKS12
(pLA25) and MKS12Placpeb1, both expressing Peb1
without its native N-terminal signal sequences. SDS-
PAGE and Western blot analysis with anti-Peb1 antibo-
dies showed that the cellular concentration of Peb1 was
approximately 50% lower in MKS12Placpeb1 than in
MKS12 (pLA25), but the protein was clearly present in
the periplasm in both strains. We estimated on the basis
of SDS-PAGE analysis that the percentage of intracellu-
lar Peb1 found in the periplasm was 50% in MKS12
(pLA25) and 25% in MKS12Placpeb1. Peb1 was not
detected in the control strains MKS12 and MKS12
(pMCS3’UTR) (Figure 1B). Western blot analysis with
antibodies against the intracellular RNA polymerase b
subunit (RNAP) indicated that the periplasmic fractiona-
tion was successful and that the presence of Peb1 in the
periplasmic samples was not due to cytoplasmic con-
tamination (bottom panel in Figure 1B). The results
thus indicated that mature Peb1 is exported to the peri-
plasm in E. coli and that the localization of Peb1 in the
periplasm is apparently not related to leakage of signifi-
cantly overexpressed protein.
Table 1 Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristics Source or
reference
Strains
E. coli AAEC072A MG1655 ΔfimA-H [44]
E. coli MKS12 MG1655 ΔfimA-H ΔfliCD [21]
E. coli
MKS12Placpeb1
MKS12 carrying peb1 under Plac at the ΔfliC site This study
E. coli MKS111 MG1655 ΔfimA-H ΔfliCD ΔflgM This study
E. coli
MKS111ΔHBB
MG1655 ΔfimA-H ΔfliCD ΔflgM ΔfliFGH ΔflgDEFGHIJ This study
E. coli DH10B endA- RecA- Dam/Dcm+ [66]
Plasmids
pMCS3’UTR Multiple cloning site preceding the 3’UTR sequence of fliC in PvuI-EcoRI of pBR322 [21]
pPeb15’3’ 173 bp fliC promoter sequence and 702bp fragment encoding mature Peb1 in PvuI-ScaI site of
pMCS3’UTR
[21]
pLA25 PfliC and fragment encoding mature Peb1, named fliC5’UTR-peb1,i nBglII-XbaI site of pMCS3’UTR This study
pLA26 3’UTR removed by digestion at ScaI-EcoRI sites of pLA25 This study
pLA31 Fragment containing PfliC and truncated fliC (encoding N-terminal 183 aa) in BglII-XbaI site of
pMCS3’UTR
This study
pLA32 Fragment containing PfliC, truncated fliC (encoding N-terminal 20 aa) and peb1 (without ss) in BglII-XbaI
site of pLA25
This study
pTAR15G Insertion of five glycines at residue D42 of Peb1. pLA25 background. This study
pTAR1P Substitution of four separate polar residues in Peb1 TAR1 region with alanine. pLA25 background. This study
pTAR2P Substitution of four separate polar residues in Peb1 TAR2 region with alanine pLA25 background. This study
pTAR1A Substitution of seven residues in Peb1 TAR1 region with alanine. pLA25 background. This study
pTAR1G Substitution of seven residues in Peb1 TAR1 region with glycine. pLA25 background. This study
pTAR2A Substitution of eight residues in Peb1 TAR2 region with alanine. pLA25 background. This study
pTAR2G Substitution of eight residues in Peb1 TAR2 region with glycine. pLA25 background. This study
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Peb1 export, we analyzed periplasmic and cell samples
of MKS12 (pLA25) grown in the presence and absence
of subinhibitory concentration of azide, which is known
to arrest SecA-YEG dependent export across the CM
[24]. Results from SDS-PAGE analysis and Western
blotting with anti-Peb1 antibodies revealed that the pre-
sence of Peb1 in the cytoplasm and the periplasm was
not affected by growth in the presence of 3 mM NaN3
(data not shown). The data thus indicate that the SecA-
YEG pathway may not be involved in the export of Peb1
across the CM.
Fusion of a FliC fragment to the N-terminus of Peb1 does
not affect secretion
We next assessed whether the N-terminus of Peb1 is
involved in the secretion process, as has been reported for
flagellar proteins and effector proteins in type 3 secretion
systems [22,25]. The plasmid pLA32 encoding the fusion
protein FliC1-20Peb1 was constructed and the protein
expressed in the E. coli strains MKS12 and MKS111ΔHBB.
SDS-PAGE and Western blot analysis with anti-Peb1 anti-
bodies showed that the intracellular expression and extra-
cellular secretion of FliC1-20Peb1 was at the same level as
those of Peb1. FliC1-20Peb1 and Peb1 were also present in
almost equal quantities in the periplasm of all the strains
studied (Figure 1C). The periplasmic location of Peb1 and
FliC1-20Peb1 was not due to cytoplasmic contamination as
indicated by the Western blot analysis with antibodies
against the intracellular protein RNAP (Figure 1C). The
results thus revealed that fusion of a heterologous protein
fragment to the processed N-terminus of Peb1 does
not interfere with Peb1 secretion in MKS12 and
MKS111ΔHBB, and that this fusion protein is secreted
equally efficiently in both strains.
Exhaustive search for transport-affecting regions in Peb1
To identify regions in Peb1 putatively important for its
transport, we constructed an exhaustive library of 5
amino acid insertion mutants .T h et a r g e tf o rt h em u t a -
genesis was the DNA fragment fliC5’UTR-peb1,i n
which peb1 is expressed from the PfliC promoter without
the sequences encoding the N-terminal leader peptide
and the putative processing site for signal peptidase II of
Peb1. The coverage of the library was determined by
DNA sequencing of the fliC5’UTR-peb1 fragment in all
the 2037 library clones. The sequence of peb1 was suc-
cessfully determined in 1827 clones and 1518 of these
carried the pentapeptide inserts in the open reading
frame of peb1. We found unique inserts at 178 sites in
total along the entire amino acid sequence of Peb1,
which is 233 amino acid residues in length. The longest
region lacking mutations was only four amino acid resi-
dues in length (Figure 2A).
Figure 1 Analysis of localization and secretion of expressed
proteins in flagellar mutant strains. (A) Western blot analyses
with anti-Peb1 and anti-flagella antibodies of whole cells and cell-
free culture supernatants from the strains indicated above the
panels and expressing wt Peb1 (from pLA25) and FliC1-183 peptide
(from pLA31), respectively. Note secretion of Peb1 in MKS111ΔHBB
but lack of FliC1-183 secretion in the same strain. (B) Subcellular
localization of Peb1 expressed from a plasmid or from the
chromosome. Top panel shows SDS-PAGE and middle panel
Western blot analysis with anti-Peb1 antibodies of whole -cell
samples and periplasmic extracts of MKS12 (pLA25), MKS12Placpeb1,
MKS12 (pMCS3’UTR), and MKS12. Lack of cell lysis and cytoplasmic
leakage was controlled by immunoblotting with anti-RNAP
antibodies (bottom panel). (C) SDS-PAGE (top panel) and Western
blot (middle panel) analyses of whole cell, cell-free culture
supernatant and periplasmic samples of strains MKS12 and
MKS111ΔHBB carrying the plasmids pLA25 (encodes Peb1) and
pLA32 (encodes FliC1-20Peb1). Lack of cytoplasmic leakage was
controlled by immunoblotting with anti-RNAP antibodies (bottom
panel). In all the panels of the figure, the letter C indicates whole-
cell samples, S cell-free culture supernatants, and PP periplasmic
extracts. All the samples correspond to 100 μl of culture and
molecular weight markers in kDa are indicated on the left.
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screened the 2037 library clones for Peb1 secretion by
dot blotting of cell-free culture supernatants with anti-
Peb1 antibodies. In the majority of Peb1-expressing
mutants analyzed, the pentapeptide insertion in the
amino acid sequence of Peb1 had no significant effect
on secretion of Peb1 into the growth medium. Interest-
ingly, we found 14 clones that showed impaired extra-
cellular export of Peb1. When we analyzed the deduced
amino acid sequence of these mutants, we noted that
the pentapeptide insertions occurred at two confined
regions in the Peb1 sequence: D42-V43 and S173-L180.
The two regions were named Transport Affecting
Regions 1 and 2 (TAR1 and TAR2; see Figure 2A). Six
of the transport-affecting insertions were localized to
the TAR1 region and eight to the TAR2 region.
We verified by SDS-PAGE and Western blot analysis
using anti-Peb1 antibodies that the absence of the TAR
mutants in the extracellular milieu was not due to
impaired Peb1 expression or degradation of the protein.
Results from the analyses of cells and cell-free culture
supernatants of mutants representative of the entire
data set are shown in Figure 2B. According to our ana-
lysis, the TAR1 mutant proteins were not degraded but
expressed intracellularly at lower quantities than wt
Peb1 (see top panel of Figure 2B), which compromised
the judgement of the effect of these mutations on Peb1
secretion. The intracellular expression of TAR2 mutant
proteins was equal to that of wt Peb1. Cell lysis was
analyzed using antibodies against intracellular marker
proteins as described previously [21] and was judged to
be minimal (bottom panels of Figure 2B). The finding
Figure 2 Mutagenesis of Peb1 as well as analysis of Peb1 expression and secretion in representative mutant library clones.
(A) Distribution of the five-residue MGS-generated insertions in Peb1 and schematic presentation of Peb1 with the transport-affecting regions
TAR1 (pink) and TAR2 (yellow) identified on the basis of the transposon mutagenesis indicated. (B) SDS-PAGE analysis of cell-free culture
supernatant of MKS12 carrying the plasmids indicated (top panel). Western blot analysis with anti-Peb1 antibodies shows the level of Peb1
expression in whole bacterial cells of the various clones (second panel from the top) and verifies that the secreted protein is Peb1 (third panel
from the top). Western blot analysis with anti-GroEL antibodies in cells and supernatants was used for assessment of cell lysis (two bottom
panels). Mutants p9G2 and p4G8 are examples of clones that secrete Peb1 well (neutral mutants) and carry the insertions at positions H25 and
G106, respectively. Mutants p4G10 and p4B7 have the insertion in the TAR1 region, whereas the insertion is in the TAR2 region in mutants p3D9
and p8C3. Mutant p1B6 has an insertion in the promoter region (at -87 nt) of the fliC-peb1 construct, which abolishes Peb1 expression. Wt Peb1
is encoded by plasmid pLA25 and pMCS3’UTR is the vector control. Cell-free culture supernatant (S) and whole bacterial cell samples
(C) corresponding to 100 μl of bacterial culture were analyzed. Molecular weight markers in kDa are indicated on the left.
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in the growth medium was additionally considered as an
internal control for lack of leakage from or lysis of the
cells.
When we compared the amino acid sequences of the
inserted pentapeptides in TAR1, TAR2 and neutral
mutants, we found that the neutral mutants carried
insertions with similar residues as the secretion-affected
mutants, but in locations outside the identified TAR
regions. We deduced that the secretion-deficient pheno-
type of TAR1 and TAR2 mutants was not dependent on
the type of sequence inserted and that the lack of extra-
cellular localization by the TAR mutants was apparently
due to the site of insertion (See Table 2 for examples).
Taken together, the exhaustive search for transport-
affecting domains in Peb1 revealed two insertion-
sensitive regions in the open reading frame of Peb1,
TAR1 and TAR2, which affect its localization in the
growth medium of E. coli MKS12.
Effect of targeted mutations in TAR regions on Peb1
secretion
The results obtained from the mutant library of Peb1
indicated the two TAR areas in the protein as critical
for its extracellular localization. To analyze these
regions of Peb1 in more detail, we substituted all the
charged and polar residues in the vicinity of and within
the TAR1 region (Glu40, Asp42, Lys45 and Lys49)
(encoded by plasmid pTAR1P) and in the TAR2 region
(Ser173, Asp175, Lys176 and Ser177 (encoded by plas-
mid pTAR2P) with alanine (Figure 3). In addition, we
generated an insertion of five Gly between Asp42
and Val43 in the TAR1 region (encoded by pTAR15G)
(Figure 3). The Ala point mutations in TAR2 did not
significantly influence the expression and secretion of
the mutated Peb1 proteins, whereas in TAR1 the cellu-
lar concentration and, as a consequence, secretion levels
of the Ala point mutants were slightly decreased. The
cellular concentration of pentaglycine insertion mutant
was also diminished and its transport was abolished
(Figure 3).
We next assessed the impact of the TAR1 and TAR2
regions on Peb1 secretion by creating long Ala substitu-
tions (Glu40 to Leu46 and Val174 to Tyr182) and for
comparison, identical Gly substitutions were constructed
(Figure 3). The mutant Peb1 proteins with nine residues
long Ala or Gly substitutions in region TAR2 (encoded
by pTAR2A and pTAR2G) were synthesized at the level
of wt Peb1 but were not secreted, whereas the Peb1
mutants carrying seven-residue long Ala or Gly substitu-
tions in TAR1 (pTAR1A and pTAR1G) showed a lower
amount of Peb1 in cells compared to the wild type
strain. The mutant with a long Gly substitution was not
Table 2 Sequence and localization of insertions present in Peb1 mutants
Localization
a)
TAR1
Plasmid Sequence Localization
a)
TAR2
Plasmid Sequence Localization
a)
outside TAR1 and TAR2
Plasmid Sequence
D42 p4G5 DAAAV S173 p8C3 VRPHS A2 pC1B11 DAAAA
D42 p4G10 CGRID V174 p9B8 VRPHV H25 p4G8 CGRTH
D42 p8E2 CGRID D175 p2C3 CGRID R89 pC18B11 CGRKR
D42 p7F4 VAAAD L179 p3D9 LRPQL I105 p9G2 GAAAI
V43 p4B7 CGRNV L179 p3B7 LRPQL T133 pC4E1 MPRQT
V43 p9D5 AAAAV L180 p10B2 VRPQL E220 pC6B3 LRPQE
L180 p8F7 VRPQL H221 pC7B5 CGRKH
L180 p4B10 VRPQL H221 pC18H10 AAAEH
a) amino acid residue after which the pentapeptide is inserted
Figure 3 Expression and secretion of site-specifically mutated
Peb1. The amino acid sequence of mature Peb1 shows the TAR1
and TAR2 regions in pink and yellow, respectively. Dots indicate
sites for Ala point substitutions (encoded by plasmids pTAR1P and
pTAR2P), the underlined sequences show sites for longer Ala and
Gly substitutions (pTAR1A, pTAR1G, pTAR2A and pTAR2G), and the
arrow indicates the site of a pentaglycine insertion (pTAR15G). Every
tenth residue is indicated by a vertical line. The bottom panel
shows whole cells (C) and cell-free culture supernatants (S) from
strain MKS12 carrying the plasmids indicated above the panels
analyzed by Western blotting using anti-Peb1 antibodies (see
Fig. 2A and Table 1 for details regarding the plasmids). Wt Peb1 is
encoded by the plasmid pLA25. Samples correspond to 100 μlo f
culture. Molecular weight markers in kDa are indicated on the left.
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was present in barely detectable amounts in the growth
medium (Figure 3).
The results thus showed that selected Ala point sub-
stitutions in TAR1 and TAR2 regions do not affect Peb1
secretion significantly, whereas longer Ala substitutions
in TAR1 and especially in TAR2 markedly impair Peb1
secretion. Also long Gly substitutions in the TAR
regions and the insertion of five Gly in TAR1 affected
transport of Peb1. In addition, the results showed that
all manipulations performed in the TAR1 region, i.e.
insertions, selected point substitutions as well as long
substitutions, affected the amount of intracellular Peb1
whereas manipulations of the TAR2 region did not.
Cytosolic Peb1 proteins are soluble and not subjected to
aggregation
To assess whether intracellular aggregation of mutant
proteins was the reason for the lack of their presence in
the growth medium, the cytoplasmic content of E. coli
MKS12 expressing Peb1 and its mutants was fractio-
nated by ultracentrifugation, separated by SDS-PAGE,
and analyzed by Western blotting using anti-Peb1 anti-
bodies (Figure 4). The experiment included wt Peb1,
Peb1 with Ala- and Gly-substituted TAR regions, Peb1
carrying a pentaglycine insertion in TAR1, and one of
the Peb1 mutants from the transposon library with the
pentapeptide insertion in the TAR1 region (encoded by
plasmid p9D5; see Table 2). The results showed that all
the proteins that were expressed well in the cells were
also found in the soluble fraction. The Peb1 mutant
with a long Gly substitution in TAR1 (encoded by
pTAR1G) was expressed very poorly and was therefore
detected neither in the soluble nor the insoluble frac-
tion, a fact hampering the analysis of its solubility. Con-
clusively, the results indicated that the lack of
extracellular localization by Peb1 mutants in the ana-
lyses was not due to aggregation or proteolysis of the
proteins in the cytoplasm.
Subcellular localization of Peb1 mutants
To analyze the localization of Peb1 mutants, we pre-
pared periplasmic fractions and cell samples of selected
mutants which expressed Peb1 well but showed
decreased Peb1 secretion. SDS-PAGE and Western blot
analysis with anti-Peb1 antibodies showed that mutant
Peb1 proteins with pentapeptide insertions or long Ala
substitutions in the TAR1 and TAR2 regions were pre-
sent in the periplasm at quantities almost equal to those
of wt Peb1 (Figure 5). Western blot analysis with antibo-
dies against the intracellular protein RNAP indicated
that the presence of Peb1 and its mutants in the peri-
plasmic samples was not due to cytoplasmic contamina-
tion (bottom panel in Figure 5). The results thus
revealed that Peb1 mutants, which are well expressed in
the cytoplasm but not secreted, are also transported
almost as efficiently as wt Peb1 into the periplasmic
space.
Figure 4 Intracellular solubility analysis of wt and mutated
Peb1 proteins. The top panels show SDS-PAGE analysis of Peb1
expression in whole bacterial cells of MKS12 carrying the plasmids
indicated above the panels. Cells were lysed and the cytoplasmic
content was fractionated by ultracentrifugation as explained in
methods section. Samples correspond to 100 μl of culture (top
panel). The lower panels show Western blot analysis with anti-Peb1
antibodies of samples from the insoluble and soluble fractions.
Samples correspond to 30 μl of culture. Plasmid pLA25 encoded wt
Peb1, see Fig. 3 and Table 1 for details regarding the other
plasmids. Molecular weight markers in kDa are indicated on the left.
The letter E indicates expression, IF insoluble fraction, and SF
soluble fraction.
Figure 5 Subcellular localization of Peb1 mutants.S D S - P A G E
(top panel) and Western blot (middle panel) analysis with anti-Peb1
antibodies of whole-cell samples and periplasmic extracts of MKS12
carrying the plasmids indicated. Cell lysis and cytoplasmic leakage
was controlled by immunoblotting with anti-RNAP antibodies
(bottom panel). Plasmids p9D5 and p8C3 carry insertions with no or
minor effect on Peb1 expression and secretion efficiency, pTAR1A
and pTAR2A carry long Ala substitutions in the corresponding TAR
regions. Note the presence of Peb1 and its mutant derivatives in
the periplasm of MKS12. The letter C indicates whole-cell samples, S
cell-free culture supernatants, and PP periplasmic extracts. All the
samples correspond to 100 μl of culture and molecular weight
markers in kDa are indicated on the left.
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We performed sequence analysis of Peb1 in order to
identify sequences important for its transport. The soft-
ware programs SignalP, TatP, LipoP and Type-III effec-
tor prediction were used for prediction of putative
signal sequences in the amino acid sequence of mature
Peb1 (shown in Figure 3) andt h u sl a c k i n gt h eS e c A -
YEG -dependent signal sequence and the putative signal
peptidase II recognition site [26-29]. We found no indi-
cation of the presence of a signal sequence related to
SecA-YEG, Tat, lipoprotein or type 3 secretion system
pathways in the mature Peb1. Interestingly, the Secreto-
meP [30] software predicted Peb1 to be a non-classically
secreted protein.
Since the TAR regions were found to have a major
impact on Peb1 secretion efficiency, we analyzed the
sequence and the structure of Peb1 with emphasis on
the TAR regions in order to identify possible structural
aspects important for secretion. Mature Peb1 is a globu-
lar protein of 233 amino acids that folds into two
domains both comprising of a five-stranded beta sheet
surrounded by alpha helices, and it binds two Zn
2+
cations (Figure 6A). The TAR1 and TAR2 regions coin-
cided with the first helix of the N-terminal core struc-
ture (Na1) (Figure 6A, B) and with the end of the third
C-terminal beta strand and the following helix (Cb3-
Ca3) (Figure 6A, C), respectively. The structural analysis
here considered only the Ala substitutions since the
pentapeptide insertions generated by the transposon
mutagenesis are challenging to analyze in structural
terms and interpretation of the effects of the Gly substi-
tution in TAR1 was not reliable due to the decreased
Peb1 expression (See Figure 3).
The helix Na1, that covers the TAR1 region, is a
14-residue long, straight and strongly amphiphilic helix
that interacts via Ser50 with one zinc cation but is not
part of the ligand-binding site of Peb1. The polar residues
of Na1 form strong interactions with the two terminal
helices of Peb1, Za1a n dZ a2, and the large apolar resi-
dues pack tightly to Za2. The helix structure is stabilized
by several hydrogen bonds (see Figure 6B). By the num-
ber of polar and apolar helix-helix interactions, the inter-
face between Na1a n dZ a1a n dZ a2i st h es t r o n g e s ti n
the whole protein. Substitution of all polar residues in
and close to TAR1 by alanines (pTAR1P) did not signifi-
cantly interfere with Peb1 transport, whereas a seven-
residue run of alanines covering TAR1 (pTAR1A) did so,
analogously to the results from the six amino acid trans-
poson insertions (as shown in Figure 2 and 3).
The TAR2 region of Peb1 is located in the very center
of the protein covering the end of Cb3a n dt h eb e g i n -
ning of Ca3 (see Figure 6A and 6C). It forms the
ligand-binding pocket (residues Val174, Asp175, Ile178)
along with numerous other residues from both domains.
The results from Ala substitutions in TAR2 were similar
to those in TAR1: the substitution by nine consecutive
alanines compromised secretion, while changes of only
the polar residues did not (see Figure 3). Sequence com-
parison between the secretion-deficient Peb1 constructs
and those exhibiting a wt secretion level pointed
towards an importance of the bulky hydrophobic resi-
dues Val174, Ile178, Leu179 and Leu180 for Peb1 secre-
tion. Except for Leu180, these are fully buried residues,
with solvent exposed surface areas smaller than 3% of
their total area. Taken together, the structural analysis
of TAR regions showed that the TAR1 region comprises
a densely packed and highly stable part of Peb1 and the
TAR2 region is located in the center of protein forming
the ligand-binding pocket along with several other resi-
dues. We suggest that the unifying feature of the TARs
is their crucial role for proper folding of Peb1, which
apparently is important for the export across the OM.
Discussion
When the Peb1 protein of C. jejuni is expressed without
its native N-terminal signal sequence and without the
putative signal peptidase II cleavage site in E. coli
MKS12 (ΔfliCfliD), it is still efficiently secreted into the
growth medium. The extracellular presence of Peb1 in
MKS12 is not due to leakage from or lysis of the cells,
as we have demonstrated previously [21]. Here, our
aims were to analyze the molecular mechanisms behind
the secretion competency of the heterologous model
p r o t e i nP e b 1i nt h eE. coli host in order to broaden our
understanding of factors that may affect secretion of
proteins in E. coli. A detailed knowledge of mechanisms
of extracellular transport of heterologous proteins in
E. coli is of great importance in the development of
secretion systems for biotechnological applications [4].
The present work shows that secretion of mature Peb1
into the growth medium of E. coli is facilitated also in the
absence of the flagellar machinery as shown in the
MKS12 derivative MKS111ΔHBB, a strain which comple-
tely lacks the flagellar secretion complex. The hypothesis
of a flagellar-independent secretion mechanism was
further supported by the fact that fusion of an N-terminal
FliC fragment to the N-terminus of Peb1 did not inter-
fere with its secretion. Our finding that Peb1 is also pre-
sent in the periplasm strongly indicates that the protein
is secreted by a mechanism that involves at least two
export steps, one across the CM to the periplasm and
another across the OM. This excludes secretion depen-
dent only on the flagellar machinery, which is known to
proceed from the cytoplasm to the extracellular milieu
without involvement of a periplasmic step [22].
A comprehensive pentapeptide scanning mutagenesis
of Peb1 was performed to decipher transport affecting
regions in the molecule itself, and the results were
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fications of only two distinct areas, named TAR1 and
TAR2, in Peb1 affected secretion. This phenomenon
was not due to insolubility or aggregation of the mutant
proteins in the bacterial cytoplasm as shown by cell
fractionation analysis. However, manipulations in the
TAR1 region affected the intracellular amount of Peb1,
whereas no such effect was observed after mutagenesis
of the TAR2 region. We anticipate that the reduced
amount of Peb1 seen in the cells of TAR1 mutants is
due to decreased expression levels. As no degradation
products of Peb1 were detected, we assume that signifi-
cant proteolysis of Peb1 mutants did not occur. The
results showed that also well-expressed, secretion-
deficient Peb1 mutants were present in the periplasmic
space. This finding strongly indicated that the export of
the TAR1 and TAR2 mutants across the CM was unen-
cumbered, whereas their further export across the OM
was compromised and led to the observed lack of Peb1
mutants in the culture supernatant.
The secretion-deficiency of TAR mutants was studied
also by analyzing the Peb1 structure. The effect of
TAR1 mutations could lie in the importance of the
hydrophobic surface packing toward the rest of the pro-
tein. Native-like amphiphilicity of Na1 may be needed
for the folding of Peb1, and inability to fold may be the
basic cause for secretion defects. The importance of
TAR2 in secretion is apparently related to the stability
of the protein, as TAR2 is located in the center of Peb1
and forms the ligand-binding pocket along with several
other residues. We suggest that the unifying feature of
the TARs is their crucial role in proper folding. We
speculate that Peb1 remains unfolded or is only partially
folded during its export across the CM to the periplasm
since mutagenesis of TAR regions did not affect this
step. Correct or at least partially correct folding of Peb1
may, on the contrary, be important for its export across
the OM into the growth medium.
Searches in the literature and publically available data-
bases revealed that the host strain MKS12 used in this
work, a ΔfliCfliD -derivative of E. coli MG1655,
expresses at the culture conditions used only three char-
acterized protein transport systems [31-34]. These are
the SecA-YEG and Tat systems, which export proteins
with cognate cleavable N-terminal signal sequences
across the CM [35], and the flagellum-specific secretion
Figure 6 Structure of Peb1. (A) An overall view of the molecular structure. The first 100 residues are colored white, and the last 133 in
greyblue, highlighting the two-domain structure of Peb1. The two pseudosymmetric domains fold into sandwiches of alternating alpha helices
and beta strands. The N and C-termini are marked with spheres. The ligand binding site is situated at the domain interphase in the middle of
the molecule, and a bound aspartate is shown as a stick model. Peb1 binds two zinc cations, which are indicated as grey spheres and marked
with Zn1 and Zn2. Pentapeptide insertion sites in the TAR1 region are colored purple, and are situated in the first helix at the core of the
N-terminal domain, Na1. Pentapeptide insertion sites in the TAR2 region are colored yellow, and cover the end of the third beta-strand at the
core of the second domain, and part of the following helix, Cb3 and Ca3. The location of the long alanine substitutions in TAR1 and TAR2 are
colored green. The two terminal helices of the protein are also marked, Za1 and Za2. In the indicated aspartate, carbons are colored green,
oxygens red and nitrogens blue. The same color scheme is used in all atomic structure. (B) A detailed view of helix Na1. The side chains of large
hydrophobic residues of Na1 are colored brown, and interactions with the surroundings are highlighted. (C) A close-up of area of the second
cluster of disruptive substitutions at the center of the molecule, next to the the ligand-binding site. Residues of the long Ala substitution in this
region are shown in green, except for three branched hydrophobic residues, V174, I178 and L179, that are drawn with thick brown lines. The
neighboring residues are shown in atomic colors. Val174, Asp175, Ile178 pack tightly to each other to form the ligand-binding pocket along with
Lys20, Ala65, Arg68, Ala82, Thr83, Phe84, Thr85, Arg90, Ala132, Thr133, Tyr157, Tyr199 from both domains.
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[36]. As indicated by the bioinformatics analysis of the
Peb1 amino acid sequence, none of these are apparently
involved in E. coli -based Peb1 secretion. The SecA-
YEG -independent secretion was here experimentally
studied by analysis of periplasmic and cell samples of
Peb1-expressing E. coli grown with or without subinhi-
bitory concentrations of azide, which is known to inhibit
protein export by the pathway [24].
Other well-characterized pathways dedicated for pro-
tein secretion in Gram-negative bacteria are normally
not expressed, or the genes are fragmented, deleted or
totally lacking in MKS12 as described below. The type 1
secretion system of E. coli, which is responsible for
secretion of the toxin hemolysin in pathogenic E. coli,i s
not found in MKS12. The strain carries the genes
encoding a hemolysin-like protein named HlyE/SheA/
ClyA secreted into the medium by a so far unidentified
mechanism in H-NS mutants [37], which MKS12 is not.
The genes encoding a putative type 2 secretion system
are present in MKS12, but the transcription of the two
operons encoding the majority of the type 2 secretion
system components is repressed by the H-NS protein
expressed in MKS12 [38]. The genes encoding a patho-
genesis-related type 3 secretion system are not present
in MKS12 [32,39]. The alternative cryptic type 3 secre-
tion system called ETT2 present in some pathogenic
and commensal E. coli s t r a i n sa sw e l la st h ea n c e s t r a l
gene cluster encoding the alternative flagellar system
Flag-2 in 20% of E. coli strains are both nonfunctional
in MKS12 [39,40]. The strain possesses at least 16 chro-
mosomal genes related to the type 4 secretion system,
but the genes are not expressed in the culture condi-
tions used in the study [41]. The type 5 secretion system
is represented in E. coli K-12 strains only by the SecA-
YEG -dependent autotransporter protein called antigen
43, which facilitates its own transport to the surface of
the cell [42]. Finally, no orthologs of the type 6 secretion
system proteins are present [43], the type 1 fimbria
genes have been site-specifically deleted in MKS12 [44],
and the curli-encoding operons are not expressed in
MKS12 at the growth conditions used [45].
ABC transporters are CM-spanning proteins that
energize the transport of their substrates by binding
and hydrolysis of ATP. In bacteria, the ABC exporters
facilitate the export of various compounds from the
cytoplasm and the more common ABC importers
import essential nutrients that are delivered by specific
PBPs [15]. In E. coli, almost 80 ABC importer and
exporter systems have been reported. These frequently
transport only small molecules [13] and are probably
not responsible for the efficient secretion of Peb1,
which is a full-length globular protein of 233 amino
acids.
The transport mechanism of the aspartate/glutamate
-binding PBP Peb1 appears to differ markedly in E. coli
from that of its structurally known homologs HBP and
GlnBP from E. coli [46,47] and Debp from Shigella flex-
neri [48]. These ABC-transporter associated PBPs are all
exported by the SecA-YEG pathway involving a cleava-
ble N-terminal signal sequence. The sequence identity
between Peb1, HBP, GlnBP and Debp is low (27% and
22%) and at the structural level, root mean square devia-
tion values calculated between mature Peb1, HBP and
Debp are only 2.2 Å since the orientation of the
domains relative to each other varies between structures.
Hence, the overall structural similarity of Peb1 with
E. coli PBPs is probably not the reason for its efficient
secretion in the heterologous E. coli host.
Our results show that in E. coli,m a t u r eP e b 1i sp r e -
sent in the extracellular milieu but cannot be visualized
on the surface of strain MKS12 (pLA25) with indirect
immunofluorecence microscopy using anti-Peb1 antibo-
dies or by electron microscopy (unpublished data) indi-
cating that blebbing of OM vesicles [49] may not be
involved in the secretion. Our results also show that
Peb1 can be exported to the periplasm independently of
the flagellar machinery, without a SecA-YEG-dependent
N-terminal signal sequence independently of the Sec
pathway, and without a signal peptidase II recognition
site. Taken together, we conclude that Peb1 may be
secreted by a still unknown secretion route, a conclusion
supported by our result from software analysis of the
Peb1 sequence indicating that the protein is secreted by
a non-classical pathway.
Our findings are indirectly supported by a line of inde-
pendent reports. According to Hu and colleagues [31] one
third of the 4225 protein-encoding genes of E. coli K-12
are functionally unannotated, a fact which makes it possi-
ble to reveal novel mechanisms even in this well-studied
organism. Proteins denoted as non-classically secreted are
found extracellularly in various bacteria despite the
absence of a defined secretion signal or motif [50,51]. Fre-
quently, these proteins called moonlighting proteins have
novel extracellular functions in addition to their well-
known roles in the cytoplasm [52]. Comparison of the
extracellular proteomes of E. coli K-12 and BL21 revealed
a large number of proteins, both cytoplasmic and periplas-
mic, to be released by unknown mechanisms into the
growth medium when cells were grown at high cell density
[53]. We assume that Peb1 is secreted in E. coli b yas t i l l
uncharacterized two-step pathway and that the structu-
rally significant TAR- regions affect the secretion. We are
currently exploring this possibility further.
Conclusions
We have previously reported that the diagnostically
interesting model protein Peb1 is efficiently secreted,
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tion and signal peptidase II, into the growth medium of
the secretion-competent strain E. coli MKS12 (ΔfliC-
fliD). Here, we analyzed the secretion mechanism
further and noticed that Peb1 was also transported inde-
pendently of the flagellar secretion machinery. We
found, by construction and analysis of an exhaustive
library of Peb1 insertion mutants, that mutagenesis of
two segments called TAR1 (residues 42 and 43) and
TAR2 (residues 173 to 180) prevented Peb1 secretion
individually. Site specific mutagenesis of the TAR
regions confirmed the importance of these regions for
Peb1 secretion, and we verified that the secretion defi-
ciency of Peb1 mutants was not due to insolubility or
aggregation of the proteins in the cytoplasm. The
mutant proteins were present in the periplasm as well
as in the cells of MKS12 and we deduced that mutagen-
esis of TAR regions did not affect export of Peb1 across
the CM, whereas its export over the OM was markedly
impaired. We conclude that the localization of the
mature model protein Peb1 in the growth medium of
E. coli i sd u et oa na c t i v es e c r e t i o np r o c e s s ,w h i c h
involves two export steps, one across the CM into the
periplasmic space and another across the OM. The
export across the OM apparently requires proper folding
of the TAR regions since mutagenesis of the regions
affected Peb1 export across the OM and thereby pre-
sence of the mutant proteins in the extracellular milieu.
Bioinformatics analysis of the Peb1 sequence indicated
that the protein is transported by an unknown, non-
classical pathway, which is a topic for further studies.
Methods
Bacterial strains and growth conditions
Bacterial strains and plasmids used in this work are
described in Table 1. E. coli strains were cultivated by
shaking in Luria broth [54] or on Luria agar plates for
16 h at 37°C supplemented with antibiotics (tetracy-
cline 12.5 μg/ml, streptomycin 100 μg/ml, ampicillin
100 μg/ml) when appropriate. For TCA-precipitation
and periplasmic isolation, the bacteria were further
inoculated (1:30) into 3 ml and 12 ml, respectively, of
N-minimal medium [54] supplemented with 0,2% casa-
mino acids and appropriate antibiotics, and cultivated
statically for 16-24 h at 37°C for optimization of pro-
tein secretion as we have described previously [21]. For
intracellular solubility assays, the strains were culti-
vated by shaking in Luria broth supplemented with
appropriate antibiotics for 18 h at 37°C followed by
dilution 1:100, and cultivated without agitation for 20
hrs at 37°C in 20 ml Luria broth with antibiotics. For
analysis of the effect of subinhibitory concentrations of
NaN3 on Peb1 export, the strains were grown as
described but in the presence of 3 mM NaN3.
Antisera and reagents
Rabbit anti-Peb1 antiserum (diluted 1:50 000 for immu-
noblot analysis) and anti-flagellum antiserum (diluted
1:2000) were available from the previous work [21]. For
control of cell lysis, polyclonal anti-GroEL antibody was
used at a dilution of 1:10 000 (Sigma-Aldrich) and
mouse monoclonal anti-RNAP at a dilution of 1:10 000
(Neoclone). Alkaline phosphatase-conjugated secondary
antibodies were obtained from DakoCytomation and
diluted to a concentration of 1.5 μg/ml (1:1000). All
antibodies were diluted in 1% BSA/PBS. Reagents for
recombinant DNA techniques and PCR were mostly
obtained from Promega. For PCR cloning and mutagen-
esis Pfu DNA polymerase (Promega) was used. Colony
PCR was performed using Dynazyme II DNA polymer-
ase (Finnzymes). Primers used in this study were pur-
chased from Medprobe and are shown in Table 3.
Construction of bacterial strains
Bacterial strains used in this work are described in Table 1.
The E. coli strains MKS111, MKS111ΔHBB and
MKS12Placpeb1 were constructed from E. coli strain
MKS12 [21] by site-specific mutagenesis using the pir-
dependent suicide vector pCVD442 as described earlier
[55]. For the construction of MKS111, a DNA fragment
covering 2348 bp (nucleotides1128017-1130365) was
amplified by PCR to contain an in-frame deletion of flgM
(367 bp, nucleotides1129426-1129059). Chromosomal
deletions of flgDEFGHIJ and fliFGH were performed to
create the E. coli strain MKS111ΔHBB using the same
principle as above. The genes flgDEFGHIJ were first
deleted from the chromosome of MKS111 using a PCR-
amplified fragment covering 6782 bp (nucleotides
1130748-1137529) containing a deletion of flgDEFGHIJ
(4905 bp, nucleotides 1131696-1136600). From this strain
fliFGH was then chromosomally deleted by the same prin-
ciples; the DNA fragment of 5589 bp (nucleotides
2010111-2015699) contained the deletion of fliFGH (3329
bp, nucleotides 2011212-2014541). For the construction of
strain MKS12Placpeb1, a 3066 bp DNA fragment was
amplified by PCR to contain fliC flanking regions (nucleo-
tides 199936-2000133 and nucleotides 2001784-2003814
with the exception of the fliD deletion, nucleotides
2002082-2003109), Plac, fliC 5’ UTR and peb1 lacking its
signal sequence. This fragment was used for substitution,
by homologous recombination, of fliC in strain MKS1
[56]. Primers used in mutagenesis were designed on the
basis of the nucleotide sequence of E. coli MG1655 and,
for the Plac promoter, E. coli DH1 (GenBank Accession
numbers NC 000913 and CP001637.1) [57]. Chromosomal
DNA of E. coli MG1655 ΔfimA-H, also called AAEC072A,
and plasmid pTSF12 [58], were used as templates for PCR
amplifications. The genotypes of the mutants were con-
firmed by PCR and Southern blot hybridization.
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Plasmids used in this work are described in Table 1.
T h ea u t h e n t i c i t yo ft h ec o n s t r u c th a sb e e nv e r i f i e df o r
each plasmid by sequencing. Plasmids pMCS3’UTR and
pPeb15’3’ were available from the previous work [21].
Our former results indicated that the 5’ UTR of fliC is
important for secretion of Peb1 in MKS12, whereas
expression of peb1 from e.g. the promoter and 5’UTR of
the ß-lactamase-encoding gene rendered Peb1 in the
cytoplasm of MKS12 [21]. Therefore, in the current
study all the peb1 constructs were generated to maintain
the sequence corresponding to the 5’ region of fliC
mRNA and thereby facilitate secretion of the gene pro-
duct. To construct pLA25 a DNA fragment containing
the peb1 gene, without the sequence encoding the leader
peptide, fused to the 173 bp 5’UTR of fliC that includes
PfliC , was constructed by PCR amplification from
pPeb15’3 with primers containing BglII and XbaI restric-
tions sites (primers 5’UTRfwBglIl and Peb1RXbaI). This
DNA fragment was ligated into the BglII-XbaId i g e s t e d
pMCS3’UTR and the ligation mixture was introduced
into E. coli MKS12 cells by electroporation. To con-
struct the fliC5’UTR-peb1 target for the in vitro transpo-
sition reaction, the plasmid pLA26 was generated. The
3’UTR of fliC in pLA25 was removed by ScaI-EcoRI
digestion and the cohesive ends were subjected to a
blunting reaction with Mung Bean Nuclease at a con-
centration of 5 units per μg DNA for 10 min at 37°C.
The blunt ends were ligated, and the ligation mixture
was introduced by electroporation into E. coli DH10B
cells. To construct plasmid pLA31, a fragment contain-
ing PfliC and the sequence encoding the N-terminal 183
residues of FliC was amplified from chromosomal DNA
of E. coli AAEC072A (primers 5’UTRfwBglIl and
FliC183XbaIR, respectively). The BglII-XbaI-digested
PCR fragment was cloned into pMCS3’UTR and subse-
quent ligation mixture was introduced into MKS12 by
electroporation. To create pLA32 a PCR-generated
DNA fragment containing the fliC 5’UTR and 60 nucleo-
tides from the 5’ end of the fliC gene (p20FliCGfp5’3’
[21] as template, primers 5’UTRfwBglII and peb1/
pLA25RIN) was fused to a PCR-generated peb1 frag-
ment (pPeb15’3’ as template, primers peb1/pLA25FIN
and Peb1RXbaI). This fusion fragment was cloned into
pMCS3’UTR using appropriate restriction sites (BglII
and XbaI )a n dt h el i g a t e dp l a s m i dp L A 3 2w a si n t r o -
duced into E. coli MKS12. For pTAR constructs, see
Table 1.
Table 3 Primers used in this study
Primer Application Sequence 5’-3’
Peb1RXbaI PCR GGCTCTAGATTATAAACCCCATTTTTTCGC
5’UTRfwBglII PCR GCCAGATCTGCGGGAATAAGGGGCAGAG
K1012R PCR GGTCTAGATTAACCCTGCAGCAGAGACA
FliC183XbaIR PCR GGTCTAGATTAAGTGGTAACTGTATCGTTAT
K1008OF PCR GGCGATCGGCGGGAATAAGGGGCAGAG
ORpLA15 PCR GCCGCATGCCGATAAACAGCCCTGCGTTA
pBRAhdIF Sequencing GCCTTCGTTCATCCATAGTTGCCT
pLA21R Sequencing GCCCAGTTAATCAGGTTACAACGATT
NotI mini Sequencing TGCGGCCGCA
028R Sequencing CAATTCAACTTGTAGGCCTGATA
peb1/pLA25FIN Construction of: pLA32 GATCACTCAAAATAATATCAACAAGGCAGAAGGTAAACTTGAGTC
peb1/pLA25RIN pLA32 GACTCAAGTTTACCTTCTGCCTTGTTGATATTATTTTGAGTGATC
HotNIF pTAR1P TAGCTGTTGCCGCATTGCTAGCTGCAAGTATATTGGGTG
HotNIR pTAR1P GCAATGCGGCAACAGCTACTGCGAAACCTTTAATTTCAC
HotCIF pTAR2P CGTTTGCTGTAGCCGCAGCAATATTGTTAGGTTATGTGG
HotCIR pTAR2P ATATTGCTGCGGCTACAGCAAACGCATCAACTCTTTTAG
PebGlyF pTAR15G GGCGGTGGTGGGGGCGTTGCCAAATTGCTAGCTAAAAG
PebGlyR pTAR15G GCCCCCACCACCGCCATCTACTTCGAAACCTTTAATTTC
PebAla1F pTAR1A GCAGCAGCGGCGGCCGCAGCGCTAGCTAAAAGTATATTGGGTG
PebAla1R pTAR1A CGCTGCGGCCGCCGCTGCTGCGAAACCTTTAATTTCACCTGTTG
PebGly1F pTAR1G GGCGGCGGTGGTGGCGGTGGCCTAGCTAAAAGTATATTGGGTG
PebGly1R pTAR1G GCCACCGCCACCACCGCCGCCGAAACCTTTAATTTCACCTGTTG
PebAla3F pTAR2A GCAGCCGCAGCAGCAGCGGCAGCGGCGGTGGATGATAAAAGTGAAATTTTG
PebAla3R pTAR2A CGCCGCTGCCGCTGCTGCTGCGGCTGCAGAAAACGCATCAACTCTTTTAG
PebGly3F pTAR2G GGCGGCGGTGGTGGCGGGGGCGGTGGTGTGGATGATAAAAGTGAAATTTTG
PebGly3R pTAR2G ACCACCGCCCCCGCCACCACCGCCGCCAGAAAACGCATCAACTCTTTTAG
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To analyze the presence of Peb1 and mutant proteins in
the growth medium, we precipitated culture superna-
tants with TCA as described previously [21]: 1,5 ml of
culture in N-minimal medium was centrifuged in a
tabletop centrifuge (Biofuge 13, Heraeus Instruments) at
13 000 rpm for 15 min at 4°C. The supernatant was
recentrifuged, and 1ml of the secondary supernatant was
precipitated with 10% TCA on ice for 30 min. Precipi-
tates were pelleted (as above) and washed twice with ice
cold ethanol/ether (1:1). Precipitated protein was
allowed to dry before resuspension into loading dye and
boiled for 5 min. An amount corresponding to 1 ml ori-
ginal cultivation when analyzed by SDS-PAGE and to
100 μl cultivation when analyzed by western blotting,
respectively, was loaded onto the gel. Cell samples were
generated by pelleting the cultivation followed by a
wash with PBS. Cells were then resuspended into appro-
priate volume of loading dye for the analysis of the
amount corresponding to bacterial cells from 100 μl cul-
ture, and boiled.
Isolation of periplasmic contents
To assess the presence of Peb1 and mutant proteins in
the periplasmic space, contents of the periplasm were
isolated. Bacteria were grown overnight in Luria broth
and diluted in N-minimal medium (1:30) for further
cultivation for 20 hrs without agitation at 37°C. Cells
were then pelleted using a F21-rotor (FiberLite®, Pira-
moon Technologies, Inc.) in a Sorvall RC-5B centrifuge
(Du Pont Instruments) at 10 000 g (15 min, 4°C). Cells
were resuspended in 4 ml 20% glucose/g wet cells and
incubated 5 minutes at RT. Next, the sample was cen-
t r i f u g e df o r5m i na t1 3 . 0 0 0r p m( R T )i nt a b l e t o pc e n -
trifuge (PICO 17, Thermo Scientific). The pellet was
further resuspended in 1 ml ice cold 10 mM Tris/20
Mm EDTA (pH 7.5)/g cells, incubated on ice 10 min
and centrifuged additionally for 5 min (13 000 rpm,
4°C). The remaining supernatant represented the peri-
plasmic content. All SDS-PAGE and Western blot ana-
lyses contained periplasmic contents corresponding to
100 μl original culture as to be comparable with cell
and TCA-precipitation samples.
Intracellular solubility assay
To separate the soluble and insoluble protein fractions
of the bacterial cytoplasm, we performed fractionation
by ultracentrifugation. The expression sample (100 μl)
was removed after 18 h cultivation and centrifuged for
10 min at 10 000 × g. The pellet was resuspended in
SDS-PAGE sample buffer and boiled for 5 min prior to
loading onto gel. The remaining portion of the over-
night culture was centrifuged for 10 min 3500 rpm in a
tabletop centrifuge and washed once with 10 ml PBS.
The pellet was resuspended in 5 ml PBS and sonicated
(in a Vibracell apparatus, So n i c s&M a t e r i a l sI n c . ,t i p
model CV26) 10 × 10 sec at 20% amplitude to lyse the
cells. The cytoplasmic content was cleared by centrifu-
gation in a tabletop centrifuge (Biofuge 13, Heraeus
Instruments) for 15 min at 6000 rpm (4°C). The super-
natants were subsequently fractionated by ultracentrifu-
gation for 1 h at 4°C with a Ti 50 rotor for 100 000 × g
(Beckman L-60 Ultracentrifuge). The supernatant con-
sisting of the soluble fraction of the cytosolic content
was removed and the pellet, representing the insoluble
fraction, was resuspended in PBS. Samples for SDS-
PAGE analysis, corresponding to 100 μl cultivation,
were prepared by adding SDS-PAGE sample buffer and
boiling for 5 min before loading onto gel. In Western
blot analysis of soluble and insoluble fractions the sam-
ples corresponded to 30 μl cultivation.
Western blotting and SDS-PAGE analysis
Western blotting and SDS-PAGE analyses were carried
out essentially as described using 15% SDS-polyacryla-
mide gels [21]. In Western blotting, nitrocellulose mem-
b r a n ew i t hp o r es i z e0 . 2μmo r0 . 4 5μm( P r o t r a n
Whatman®, Schleicher&Schuell), was used. Blocking
with 2% BSA/PBS was done for 18 h at RT, and detec-
tion employed appropriate antibodies.
Generation of the insertion mutant library
Insertion mutagenesis of the DNA fragment fli-
C5’UTR-peb1 was accomplished using the Mutation
Generation System (Finnzymes) that employs MuA
transposase to insert an artificial transposon randomly
into a target plasmid [59]. Upon transposon elimina-
tion by restriction digestion and plasmid recirculation
by ligation, the system yields fifteen base pair inser-
tions in target plasmids [60,61]. The in vitro transposi-
tion reaction was essentially done according to
instructions supplied by the manufacturer. The reac-
tion contained 100 ng M1-CamR transposon DNA as a
donor, 480 ng plasmid pLA26 as a target, 0.2 μgM u A
transposase, 25 mM Tris-Hcl, pH 8.0, 100μg/ml BSA,
1 5 %( w / v )g l y c e r o l ,1 0 0m MN a C l ,0 ,0 5 %T r i t o nX -
100 and 10 mM MgCl2 in a total volume of 25 μl. The
reaction was conducted at 30°C for 3 h. The DNA was
purified, precipitated, and transformed into E. coli
DH10B cells by electroporation. The plasmid DNA was
isolated from a pool of 90 000 colonies using the
Plasmid Maxi Kit (Qiagen). Subsequently, the
fliC5’UTR-peb1 target fragment was removed by BglII-
XbaI digestion and ligated with equally digested
pMCS3’UTR. The body of the transposon was removed
by NotI digestion after which the plasmids were recir-
culated by ligation. This pool of mutated plasmids
represented the insertion mutant library.
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For screening purposes, plasmids of the insertion
mutant library were introduced into E. coli MKS12 cells
by electroporation and transformants were randomly
picked for screening from selection plates. Primary
screening of the mutant library was based on dot blot-
ting of the cleared supernatant from cultures of library
clones. In total 2037 transformants were cultured with-
out agitation on 96-well microtiter plates in 200 μlL B
supplemented with tetracycline at 12.5 μg/ml for 16 h at
37°C and 5 μl overnight culture was subsequently trans-
ferred into 200 μl N-minimal medium supplemented
with 0.2% casamino acids and tetracycline (12.5 μg/ml)
and cultured statically for 20 hours. The cells were pel-
leted by centrifugation of the microtiter plate for 15 min-
utes at approximately 2000 × g (Heraeus Megafuge 1.0,
rotor model 2705, microtiter carrier model 2708) and
the remaining supernatants were cleared by centrifuging
150 μl supernatant for an additional 15 min at 2000 × g.
Next, 100 μl cleared supernatant was dot blotted onto
nitrocellulose membrane (pore size 0.45 μm; Protran
Whatman®, Schleicher&Schuell) using the Bio-Dot®
Microfiltration Apparatus (Bio-Rad Laboratories)
according to manufacturers’ instructions. The mem-
brane was subsequently incubated in 2% BSA/PBS for
18 h at 20°C and thereafter the presence of Peb1 protein
was detected with anti-Peb1 antibodies and alkaline
phosphatase -conjugated secondary antibodies. In order
to verify that Peb1 was expressed intracellularly, the cell
pellets from the microtiter plates were washed with 100
μl PBS, repelleted (10 min for 1000 rpm, approx. 170 ×
g) and lysed by resuspension in SDS-PAGE sample buf-
fer (30 μl) and boiling for 5 min. Samples equivalent to
30 μl of bacterial culture were analysed by SDS-PAGE.
Secondary screening of clones expressing Peb1 intracel-
lularly at the same level as wt Peb1 but showing
decreased Peb1 export was performed by precipitation
of cleared supernatants with 10% TCA and Western
blotting with anti-Peb1 antibodies as described else-
where [21]. Localization of the insertion site in the
mutated peb1 genes was done by colony PCR using
either forward (pBRAhdIF) or reverse (pLA21R) primer
together with the NotI-miniprimer (Finnzymes, Table 3.)
that recognizes the 15 bp insert originating from the
transposition event. Ultimately the insertions’ location
was specified by sequencing (Institute of Biotechnology,
University of Helsinki, Finland) using the appropriate
primers (pBRAhdIF or 028R).
Bioinformatic analysis
The amino acid sequence of mature Peb1 was analyzed
for the presence of a secretion signal using the softwares
SignalP [26], TatP [27], SecretomeP [30], LipoP [29] and
Type-III effector prediction [28]. The protein structures
were visualized with the program VMD [62]. The
sequences of bacterial periplasmic amino acid binding
proteins were aligned by ClustalX 2.0.5 [63] and the sol-
vent exposed surface area per residue was calculated
with the program GetArea [64].
Accession numbers
The accession numbers [65] of the cited atomic coordi-
nates are Peb1 [PDB:2v25], glutamine binding protein
GlnBP from E. coli [PDB:1ggg], histidine binding protein
HBP from E. coli [PDB: 1hsl], and glutamate/aspartate
binding protein Debp from S. flexnerii [PDB: 2vha]. The
cited amino acid sequence is Peb1 [GenBank:
AAA02919.1]; the genome sequences are from E. coli
MG1655 [GenBank: U00096], the parental strain of
MKS12, and E. coli DH1 [GenBank: CP001637.1] [57].
List of abbreviations used
(3’UTR): 3’ untranslated region; (5’UTR): 5’ untranslated
region; (ABC): ATP-binding cassette; (CM): cytoplasmic
membrane; (PfliC): fliC promotor; (OM): outer membrane;
(PBP): periplasmic binding protein; (PBS): phosphate-
buffered saline, pH 7,1; (BSA/PBS): bovine serum albumin
in PBS; (RNAP): RNA polymerase b subunit; (SDS-PAGE):
sodium dodecylsulphate polyacrylamide gel electrophor-
esis; (TCA): trichloro acetic acid; (wt): wild-type.
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